Mangalam Drugs and Organics Limited (MANGALAM) - Financial and Strategic SWOT Analysis Review

Market: Chemicals and Materials

India, 25 pages report, published by GlobalData

Keywords : Mangalam Drugs and Organics Limited, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Report ThumbnailOctober-2016
Summary

Mangalam Drugs and Organics Limited (Mangalam) is a chemical company that designs, develops, manufactures and supplies API and Intermediates. The company operates through product segments such as active pharmaceutical ingredients, intermediates and specialty chemicals. Its API products include allopurinol, amodiaquine HCl, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, chloroquine sulphate, dihydroartemisinin, furosemide, hydroxychloroquine sulphate and lumefantrine. Mangalam offers intermediates such as 4,7 dichloroquinoline, 2-Phenoxyaniline, phenol, 2-aminodiphenyl ether and ortho phenoxy methane sulfonanilide. The company operates through its manufacturing and in-house research and development facilities. Mangalam is headquartered in Mumbai, Maharashtra, India.

This comprehensive SWOT profile of Mangalam Drugs and Organics Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mangalam Drugs and Organics Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • List of Figures
  • Mangalam Drugs and Organics Limited, Performance Chart
  • Mangalam Drugs and Organics Limited, Ratio Charts
  • List of Tables
  • Mangalam Drugs and Organics Limited, Key Information
  • Mangalam Drugs and Organics Limited, Key Ratios
  • Mangalam Drugs and Organics Limited, Share Data
  • Mangalam Drugs and Organics Limited, Major Products and Services
  • Mangalam Drugs and Organics Limited, History
  • Mangalam Drugs and Organics Limited, Key Employees
  • Mangalam Drugs and Organics Limited, Key Employee Biographies
  • Mangalam Drugs and Organics Limited, Key Operational Heads
  • Mangalam Drugs and Organics Limited, Other Locations
  • Mangalam Drugs and Organics Limited, Subsidiaries
  • Mangalam Drugs and Organics Limited, Key Competitors
  • Mangalam Drugs and Organics Limited, SWOT Analysis
  • Mangalam Drugs and Organics Limited, Ratios based on current share price
  • Mangalam Drugs and Organics Limited, Annual Ratios
  • Mangalam Drugs and Organics Limited, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • Table of Contents
  • Section 1 - About the Company
  • Mangalam Drugs and Organics Limited - Key Information
  • Mangalam Drugs and Organics Limited - Overview
  • Mangalam Drugs and Organics Limited - Key Employees
  • Mangalam Drugs and Organics Limited - Key Employee Biographies
  • Mangalam Drugs and Organics Limited - Key Operational Heads
  • Mangalam Drugs and Organics Limited - Major Products and Services
  • Mangalam Drugs and Organics Limited - History
  • Mangalam Drugs and Organics Limited - Company Statement
  • Mangalam Drugs and Organics Limited - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • Mangalam Drugs and Organics Limited - Business Description
  • Mangalam Drugs and Organics Limited - Corporate Strategy
  • Mangalam Drugs and Organics Limited - SWOT Analysis
  • SWOT Analysis - Overview
  • Mangalam Drugs and Organics Limited - Strengths
  • Mangalam Drugs and Organics Limited - Weaknesses
  • Mangalam Drugs and Organics Limited - Opportunities
  • Mangalam Drugs and Organics Limited - Threats
  • Mangalam Drugs and Organics Limited - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • Mangalam Drugs and Organics Limited - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company

Please select a license type

Share

Related Products

GlobalDataMangalam Drugs and Organics Limited (MANGALAM) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailMangalam Drugs and Organics Limited (MANGALAM) - Financial and Strategic SWOT Analysis Review, Company ReportProduct #: 46137
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved